Iowa 2023-2024 Regular Session

Iowa Senate Bill SF2089

Introduced
1/23/24  
Introduced
1/23/24  

Caption

A bill for an act relating to ensuring the provision of accessible prescription-related measures for persons who are blind, have a visual impairment, or otherwise have print disabilities.

Impact

If enacted, SF2089 would amend existing laws governing accessibility in healthcare, particularly regarding prescription drug information. It aims to bring the standards in line with recommendations from the United States Government Accountability Office, thus improving overall public health support for individuals facing barriers related to print disabilities. The requirement for accessible drug labels is seen as a crucial step in ensuring that all consumers can effectively manage their medications and health information.

Summary

Senate File 2089, introduced by Senator Bisignano, seeks to enhance accessibility for individuals who are blind or have visual impairments and print disabilities. The bill mandates that the Iowa Board of Pharmacy adopt rules ensuring that, by October 31, 2024, all persons with these disabilities have appropriate access to prescription drug labels, bag tags, and medical guides. It emphasizes that such information must be provided at no additional cost and in a manner that ensures equality of access to information as compared to those without disabilities.

Contention

Some points of contention surrounding SF2089 may arise from the implications it could have on pharmaceutical practices and the costs associated with implementing these accessibility measures. The bill requires the Board to solicit input from affected individuals while also submitting a report on its progress to the governor and the general assembly by January 1, 2025. Concerns may include the potential increase in operational costs for pharmacies and whether they can adequately provide the necessary services without incurring additional fees that might affect consumers.

Companion Bills

No companion bills found.

Previously Filed As

IA HF2252

A bill for an act relating to ensuring the provision of accessible prescription-related measures for persons who are blind, have a visual impairment, or otherwise have print disabilities.(See HF 2456.)

IA SF2022

A bill for an act relating to ensuring the provision of accessible prescription-related measures for persons who are blind, have a visual impairment, or otherwise have print disabilities.

IA HF2456

A bill for an act relating to ensuring the provision of accessible prescription-related measures for persons who are blind, have a visual impairment, or otherwise have print disabilities.(Formerly HF 2252.)

IA SF202

A bill for an act relating to ensuring the provision of accessible prescription-related measures for persons who are blind, have a visual impairment, or otherwise have print disabilities.

IA SB940

State Board of Pharmacy - Accessible Prescription Labels, Bag Tags, and Medical Guides for Blind, Visually Impaired, and Print Disabled Individuals - Regulations

IA HB456

State Board of Pharmacy - Accessible Prescription Labels, Bag Tags, and Medical Guides for Blind, Visually Impaired, and Print Disabled Individuals - Regulations

IA SB00397

An Act Concerning Library Service For Persons Who Are Blind, Visually Impaired Or Have Other Disabilities.

IA S2118

Increasing government accessibility for persons who are blind or visually impaired

IA SF2266

Pharmacist dispensing of prescriptions using an audible container or braille container label for patients who are visually impaired or blind requirement

IA AB1902

Prescription drug labels: accessibility.

Similar Bills

CA AB577

Health care coverage: antisteering.

CA AB1178

Medi-Cal: serious mental illness: drugs.

NJ A4975

Prohibits pre-approval or precertification of medical tests, procedures and prescription drugs covered under health benefits or prescription drug benefits plans.

NJ A5571

Prohibits pre-approval or precertification of medical tests, procedures and prescription drugs covered under health benefits or prescription drug benefits plans.

NJ S469

Prohibits pre-approval or precertification of medical tests, procedures and prescription drugs covered under health benefits or prescription drug benefits plans.

NJ S2257

Prohibits pre-approval or precertification of medical tests, procedures and prescription drugs covered under health benefits or prescription drug benefits plans.

CA SB418

Health care coverage: prescription hormone therapy and nondiscrimination.

NJ S796

Prohibits pre-approval or precertification of cancer treatments, tests, procedures and prescription drugs covered under health benefits or prescription drug benefits plans.